Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth.
Lauritano EC, Gabrielli M, Lupascu A, Santoliquido A, Nucera G, Scarpellini E, Vincenti F, Cammarota G, Flore R, Pola P, Gasbarrini G, Gasbarrini A. Lauritano EC, et al. Aliment Pharmacol Ther. 2005 Jul 1;22(1):31-5. doi: 10.1111/j.1365-2036.2005.02516.x. Aliment Pharmacol Ther. 2005. PMID: 15963077 Free article. Clinical Trial.
Small intestinal bacterial overgrowth recurrence after antibiotic therapy.
Lauritano EC, Gabrielli M, Scarpellini E, Lupascu A, Novi M, Sottili S, Vitale G, Cesario V, Serricchio M, Cammarota G, Gasbarrini G, Gasbarrini A. Lauritano EC, et al. Am J Gastroenterol. 2008 Aug;103(8):2031-5. doi: 10.1111/j.1572-0241.2008.02030.x. Am J Gastroenterol. 2008. PMID: 18802998
Prevalence of small intestinal bacterial overgrowth in Parkinson's disease.
Gabrielli M, Bonazzi P, Scarpellini E, Bendia E, Lauritano EC, Fasano A, Ceravolo MG, Capecci M, Rita Bentivoglio A, Provinciali L, Tonali PA, Gasbarrini A. Gabrielli M, et al. Among authors: lauritano ec. Mov Disord. 2011 Apr;26(5):889-92. doi: 10.1002/mds.23566. Epub 2011 Feb 1. Mov Disord. 2011. PMID: 21520278
Rifaximin-based regimens for eradication of Helicobacter pylori: a pilot study.
Gasbarrini A, Lauritano EC, Nista EC, Candelli M, Gabrielli M, Santoro M, Zocco MA, Cazzato A, Finizio R, Ojetti V, Cammarota G, Gasbarrini G. Gasbarrini A, et al. Among authors: lauritano ec. Dig Dis. 2006;24(1-2):195-200. doi: 10.1159/000090330. Dig Dis. 2006. PMID: 16699278 Clinical Trial.
Association between hypothyroidism and small intestinal bacterial overgrowth.
Lauritano EC, Bilotta AL, Gabrielli M, Scarpellini E, Lupascu A, Laginestra A, Novi M, Sottili S, Serricchio M, Cammarota G, Gasbarrini G, Pontecorvi A, Gasbarrini A. Lauritano EC, et al. J Clin Endocrinol Metab. 2007 Nov;92(11):4180-4. doi: 10.1210/jc.2007-0606. Epub 2007 Aug 14. J Clin Endocrinol Metab. 2007. PMID: 17698907
Small intestinal bacterial overgrowth: diagnosis and treatment.
Gasbarrini A, Lauritano EC, Gabrielli M, Scarpellini E, Lupascu A, Ojetti V, Gasbarrini G. Gasbarrini A, et al. Among authors: lauritano ec. Dig Dis. 2007;25(3):237-40. doi: 10.1159/000103892. Dig Dis. 2007. PMID: 17827947 Free article.
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.
Nucera G, Gabrielli M, Lupascu A, Lauritano EC, Santoliquido A, Cremonini F, Cammarota G, Tondi P, Pola P, Gasbarrini G, Gasbarrini A. Nucera G, et al. Among authors: lauritano ec. Aliment Pharmacol Ther. 2005 Jun 1;21(11):1391-5. doi: 10.1111/j.1365-2036.2005.02493.x. Aliment Pharmacol Ther. 2005. PMID: 15932370 Free article.
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.
Lupascu A, Gabrielli M, Lauritano EC, Scarpellini E, Santoliquido A, Cammarota G, Flore R, Tondi P, Pola P, Gasbarrini G, Gasbarrini A. Lupascu A, et al. Among authors: lauritano ec. Aliment Pharmacol Ther. 2005 Dec;22(11-12):1157-60. doi: 10.1111/j.1365-2036.2005.02690.x. Aliment Pharmacol Ther. 2005. PMID: 16305730 Free article.
34 results